Marginal structural models for case-cohort study designs to estimate the association of antiretroviral therapy initiation with incident AIDS or death.

Authors:
Address: Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, 27599-7435, USA. cole@unc.edu
Journal:


Publication:

abstract

To estimate the association of antiretroviral therapy initiation with incident acquired immunodeficiency syndrome (AIDS) or death while accounting for time-varying confounding in a cost-efficient manner, the authors combined a case-cohort study design with inverse probability-weighted estimation of a Marginal structural Cox proportional hazards model. A total of 950 adults who were positive for human immunodeficiency virus type 1 were followed in 2 US cohort studies between 1995 and 2007. In the full cohort, 211 AIDS cases or deaths occurred during 4,456 person-years. In an illustrative 20% random subcohort of 190 participants, 41 AIDS cases or deaths occurred during 861 person-years. Accounting for measured confounders and determinants of dropout by inverse probability weighting, the full cohort hazard ratio was 0.41 (95% confidence interval: 0.26, 0.65) and the case-cohort hazard ratio was 0.47 (95% confidence interval: 0.26, 0.83). Standard multivariable-adjusted hazard ratios were closer to the null, regardless of study design. The precision lost with the case-cohort design was modest given the cost savings. Results from Monte Carlo simulations demonstrated that the proposed approach yields approximately unbiased estimates of the hazard ratio with appropriate confidence interval coverage. Marginal structural model analysis of case-cohort study designs provides a cost-efficient design coupled with an accurate analytic method for research settings in which there is time-varying confounding.



Related Articles
Using marginal structural measurement-error models to estimate the long-term effect of antiretroviral therapy on incident AIDS or death.
Am J Epidemiol. 2010
Using marginal structural measurement-error models to estimate the long-term effect of antiretroviral therapy on incident AIDS or death.
Cole SR, Jacobson LP, Tien PC, Kingsley L, Chmiel JS, Anastos K. Am J Epidemiol. 2010 Jan 1; 171(1):113-22. Epub 2009 Nov 24.
Time scale and adjusted survival curves for marginal structural cox models.
Am J Epidemiol. 2010
Time scale and adjusted survival curves for marginal structural cox models.
Westreich D, Cole SR, Tien PC, Chmiel JS, Kingsley L, Funk MJ, Anastos K, Jacobson LP. Am J Epidemiol. 2010 Mar 15; 171(6):691-700. Epub 2010 Feb 5.
Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models.
Am J Epidemiol. 2003
Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models.
Cole SR, Hernán MA, Robins JM, Anastos K, Chmiel J, Detels R, Ervin C, Feldman J, Greenblatt R, Kingsley L, et al. Am J Epidemiol. 2003 Oct 1; 158(7):687-94.
Review Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
Lancet. 2009
Review Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
When To Start Consortium, Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, Funk MJ, Geskus RB, Gill J, et al. Lancet. 2009 Apr 18; 373(9672):1352-63. Epub 2009 Apr 8.
Review Comparison of dynamic treatment regimes via inverse probability weighting.
Basic Clin Pharmacol Toxicol. ...
Review Comparison of dynamic treatment regimes via inverse probability weighting.
Hernán MA, Lanoy E, Costagliola D, Robins JM. Basic Clin Pharmacol Toxicol. 2006 Mar; 98(3):237-42.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.